BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 22399852)

  • 1. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
    Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
    Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
    Bafadhel M; Clark TW; Reid C; Medina MJ; Batham S; Barer MR; Nicholson KG; Brightling CE
    Chest; 2011 Jun; 139(6):1410-1418. PubMed ID: 21030489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
    Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia.
    Lubell Y; Blacksell SD; Dunachie S; Tanganuchitcharnchai A; Althaus T; Watthanaworawit W; Paris DH; Mayxay M; Peto TJ; Dondorp AM; White NJ; Day NP; Nosten F; Newton PN; Turner P
    BMC Infect Dis; 2015 Nov; 15():511. PubMed ID: 26558692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper-respiratory viral infection, biomarkers, and COPD exacerbations.
    Kherad O; Kaiser L; Bridevaux PO; Sarasin F; Thomas Y; Janssens JP; Rutschmann OT
    Chest; 2010 Oct; 138(4):896-904. PubMed ID: 20435659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study.
    Ye YP; Zhao H; Kang T; Zhao LH; Li N; Chen J; Peng XX
    Chron Respir Dis; 2022; 19():14799731221108516. PubMed ID: 35830291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study.
    Daubin C; Parienti JJ; Fradin S; Vabret A; Ramakers M; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
    BMC Infect Dis; 2009 Sep; 9():157. PubMed ID: 19772586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
    Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R
    COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
    Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
    Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
    Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
    BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection.
    Ingram PR; Inglis T; Moxon D; Speers D
    Intensive Care Med; 2010 Mar; 36(3):528-32. PubMed ID: 20069274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia.
    Porfyridis I; Georgiadis G; Vogazianos P; Mitis G; Georgiou A
    Respir Care; 2014 Apr; 59(4):574-81. PubMed ID: 24106319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease.
    Choi J; Oh JY; Lee YS; Hur GY; Lee SY; Shim JJ; Kang KH; Min KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():953-959. PubMed ID: 31190782
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of serum procalcitonin in diagnosing bacterial lower respiratory tract infections in people with exacerbation of Chronic Obstructive Pulmonary Disease].
    Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):389-92. PubMed ID: 16892144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbations of COPD: A prospective observational study.
    Titova E; Christensen A; Henriksen AH; Steinshamn S; Åsberg A
    Chron Respir Dis; 2019; 16():1479972318769762. PubMed ID: 29848051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
    Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
    J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
    Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis.
    Mathioudakis AG; Chatzimavridou-Grigoriadou V; Corlateanu A; Vestbo J
    Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28143877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.